This post was originally published and is credit to this site
An investigation for investors in Selecta Biosciences, Inc. (NASDAQ: SELB) shares over potential securities laws violations.
An investigation was announced concerning potential securities laws violations by Selecta Biosciences, Inc. in connection with certain financial statements.
Investors who purchased shares of Selecta Biosciences, Inc. (NASDAQ: SELB), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 – 1554.
The investigation by a law firm focuses on whether a series of statements by Selecta Biosciences, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Watertown, MA based Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Selecta Biosciences, Inc. reported that its annual Total Revenue rose from $0.9 million in 2018 to $6.67 million in 2019 and that its Net Loss declined from $65.33 million in 2018 to $55.35 million in 2019.
Shares of Selecta Biosciences, Inc. (NASDAQ: SELB) declined from $4.55 per share on February 19, 2020, to as low as $1.81 per share on April 8, 2020.
Those who purchased shares of Selecta Biosciences, Inc. (NASDAQ: SELB), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North
San Diego, CA 92108
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.